Polymorphic variants in the vitamin D pathway genes and the risk of ovarian cancer among non-carriers of BRCA1/BRCA2 mutations

By          

Oncology Letters, Vol. 11, Iss. 2, 2016-01 ,pp. : 1181-1188

Spandidos Publications

Access to resources Recommend Favorite

Histology of Prophylactically Removed Ovaries from BRCA1 and BRCA2 Mutation Carriers Compared with Noncarriers in Hereditary Breast Ovarian Cancer Syndrome Kindreds

By Casey M.J.   Bewtra C.   Hoehne L.L.   Tatpati A.D.   Lynch H.T.   Watson P.  

Gynecologic Oncology, Vol. 78, Iss. 3, 2000-09 ,pp. : 278-287

Elsevier

Access to resources Recommend Favorite

BRCA1 mutations and clinicopathological features in a sample of Italian women with early-onset breast cancer

By Turchetti D.   Cortesi L.   Federico M.   Bertoni C.   Mangone L.   Ferrari S.   Silingardi V.  

European Journal of Cancer, Vol. 36, Iss. 16, 2000-10 ,pp. : 2083-2089

Elsevier

Access to resources Recommend Favorite

Significantly lower rates of BRCA1/BRCA2 founder mutations in Ashkenazi women with sporadic compared with familial early onset breast cancer

By Gershoni-Baruch R.   Dagan E.   Fried G.   Bruchim Bar-Sade R.   Sverdlov-Shiri R.   Zelicksson G.   Friedman E.  

European Journal of Cancer, Vol. 36, Iss. 8, 2000-05 ,pp. : 983-986

Elsevier

Access to resources Recommend Favorite

The risk of ovarian cancer after breast cancer in BRCA1 and BRCA2 carriers

By Robson Mark  

The Women's Oncology Review, Vol. 5, Iss. 3, 2005-09 ,pp. : 163-164

Informa Healthcare

Access to resources Recommend Favorite